Covalent modification by isoprenoid lipids (prenylation) is increasingly being recognized as an important component in the localization and activity of many proteins involved in signal transduction pathways. The discovery that the members of the ras family of oncogene products were modified by the farnesyl (15-carbon) prenyl group, and that prenylation was required for the ras proteins to express their transforming potential, has revealed a previously unrecognized mechanism for regulation of cell growth. Furthermore, a number of ras-related proteins, members of the so- called """"""""small G protein"""""""" family, and the gamma subunits of the heterotrimeric G proteins are also now known to be prenylated - most of these proteins contain the 20-carbon geranylgeranyl group. In fact, the geranylgeranyl group appears to be the predominant prenyl group in mammalian protein modification. Geranylgeranylated proteins have been implicated in the regulation of a variety of cellular processes, including transmembrane signaling, intracellular membrane trafficking, and secretion, and a variety of studies have highlighted the importance of this prenyl modification in these regulatory pathways. The long term goal of this research project is to understand the molecular mechanisms of protein prenylation and the role that these modifications play in the targeting and biological activity of modified proteins. In particular, the emphasis will be on the 20-carbon prenyl modification, geranylgeranyl.
The specific Aims of this proposal are: l) Determination of the primary structure of the protein geranylgeranyltransferase (PGGT), the enzyme responsible for the geranylgeranyl modification of a number of key proteins involved in cellular signaling; 2) Development of cDNA expression systems for mammalian PGGT; and 3) Initiation of structure/function analysis of mammalian PGGT. The methodologies (both biochemical and molecular biological) to be employed in these studies are well-established. Accomplishment of these Aims will serve to define systems that will greatly facilitate future investigations into protein prenylation, and the role of this process in control of cellular signaling events and oncogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM046372-01A2
Application #
3305798
Study Section
Biochemistry Study Section (BIO)
Project Start
1993-08-01
Project End
1997-07-31
Budget Start
1993-08-01
Budget End
1994-07-31
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Mizrahi, Ariel; Berdichevsky, Yevgeny; Casey, Patrick J et al. (2010) A prenylated p47phox-p67phox-Rac1 chimera is a Quintessential NADPH oxidase activator: membrane association and functional capacity. J Biol Chem 285:25485-99
Cushman, Ian; Casey, Patrick J (2009) Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration. J Biol Chem 284:27964-73
Peterson, Yuri K; Wang, Xiang S; Casey, Patrick J et al. (2009) Discovery of geranylgeranyltransferase-I inhibitors with novel scaffolds by the means of quantitative structure-activity relationship modeling, virtual screening, and experimental validation. J Med Chem 52:4210-20
Ugolev, Yelena; Berdichevsky, Yevgeny; Weinbaum, Carolyn et al. (2008) Dissociation of Rac1(GDP).RhoGDI complexes by the cooperative action of anionic liposomes containing phosphatidylinositol 3,4,5-trisphosphate, Rac guanine nucleotide exchange factor, and GTP. J Biol Chem 283:22257-71
Katadae, Maiko; Hagiwara, Ken'ichi; Wada, Akimori et al. (2008) Interacting targets of the farnesyl of transducin gamma-subunit. Biochemistry 47:8424-33
Rao, P Vasantha; Peterson, Yuri K; Inoue, Toshihiro et al. (2008) Effects of pharmacologic inhibition of protein geranylgeranyltransferase type I on aqueous humor outflow through the trabecular meshwork. Invest Ophthalmol Vis Sci 49:2464-71
Leow, Jo-Lene; Baron, Rudi; Casey, Patrick J et al. (2007) Quantitative structure-activity relationship (QSAR) of indoloacetamides as inhibitors of human isoprenylcysteine carboxyl methyltransferase. Bioorg Med Chem Lett 17:1025-32
Sjogren, Anna-Karin M; Andersson, Karin M E; Liu, Meng et al. (2007) GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer. J Clin Invest 117:1294-304
Baron, Rudi A; Peterson, Yuri K; Otto, James C et al. (2007) Time-dependent inhibition of isoprenylcysteine carboxyl methyltransferase by indole-based small molecules. Biochemistry 46:554-60
Svensson, Annika W; Casey, Patrick J; Young, Stephen G et al. (2006) Genetic and pharmacologic analyses of the role of Icmt in Ras membrane association and function. Methods Enzymol 407:144-59

Showing the most recent 10 out of 57 publications